Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Cefalexin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cefalexin 500mg capsules
0501021L0AAABAB
|
Cefalexin | Cefalexin | Infections | 74,710 |
|
Cefalexin 250mg capsules
0501021L0AAAAAA
|
Cefalexin | Cefalexin | Infections | 51,960 |
|
Cefalexin 500mg tablets
0501021L0AAAHAH
|
Cefalexin | Cefalexin | Infections | 26,522 |
|
Cefalexin 250mg tablets
0501021L0AAAGAG
|
Cefalexin | Cefalexin | Infections | 25,657 |
|
Cefalexin 125mg/5ml oral suspension
0501021L0AAACAC
|
Cefalexin | Cefalexin | Infections | 11,017 |
|
Cefalexin 250mg/5ml oral suspension
0501021L0AAADAD
|
Cefalexin | Cefalexin | Infections | 10,499 |
|
Cefalexin 250mg/5ml oral suspension sugar free
0501021L0AAAPAP
|
Cefalexin | Cefalexin | Infections | 5,311 |
|
Cefalexin 125mg/5ml oral suspension sugar free
0501021L0AAANAN
|
Cefalexin | Cefalexin | Infections | 4,994 |
|
Cefalexin 500mg/5ml oral suspension
0501021L0AAAEAE
|
Cefalexin | Cefalexin | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.